| 000 | 01710 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513223409.0 | ||
| 264 | 0 | _c20001207 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm000950v _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWhite, A W | |
| 245 | 0 | 0 |
_aResistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 2000 |
||
| 300 |
_a4084-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzimidazoles _xchemical synthesis |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 |
_aTopotecan _xpharmacology |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aAlmassy, R | |
| 700 | 1 | _aCalvert, A H | |
| 700 | 1 | _aCurtin, N J | |
| 700 | 1 | _aGriffin, R J | |
| 700 | 1 | _aHostomsky, Z | |
| 700 | 1 | _aMaegley, K | |
| 700 | 1 | _aNewell, D R | |
| 700 | 1 | _aSrinivasan, S | |
| 700 | 1 | _aGolding, B T | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 43 _gno. 22 _gp. 4084-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm000950v _zAvailable from publisher's website |
| 999 |
_c11006119 _d11006119 |
||